CEACAM5 and gastric cancer: Many serum-and tissue-based biomarkers specific for GC have been identified through genomic and proteomic techniques, but only serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) have been proved to being clinically useful.